Carolina Innovations Seminar
"The Story of Oriel Therapeutics"
Thursday, January 7, 2010
5:30-6:30 p.m.
Sitterson Hall, Room 014
University of North Carolina at Chapel Hill
Dr. Paul Atkins co-founded the UNC spin-out company Oriel Therapeutics in 2002. Dr. Atkins is currently the President and Chief Operating Officer of Oriel, which was based on technology developed for dry powder inhaler devices in the lab of Dr. Anthony Hickey of the UNC School of Pharmacy. Prior to founding Oriel, Atkins spent more than ten years with GlaxoSmithKline where he established the Inhaled Product Development group and was responsible for a number of global technical development programs, including the development of HFA metered dose inhalers and novel dry powder inhalers. Oriel Therapeutics is now actively developing a portfolio of respiratory products targeted primarily at asthma and COPD. Dr. Atkins will share the journey of Oriel and their progression from the academic lab to the initiation of clinical trials.
For more information about the OTD seminars, go to:
http://research.unc.edu/otd/carolina_innovations_seminar.php
Live Feeds Disclaimer
The live feeds below are provided direct from the source, including public and private sector sources such as the FDA, Medical Product Manufacturing News, BioSpace, and Twitter Feeds.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
MedCity News » North Carolina
- First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
- How UNC Health Saved Over $5M On Annual Nurse Turnover Costs
- How Genome Sequencing Can Broaden the Scope of Newborn Screening
- While Auto vs. Allo Cell Therapy Debate Continues, VCs Look for ‘Next Shiny Thing’
- Precision Bio Offloads Lead Cell Therapy Program in Pivot to In Vivo Gene Editing
FDA's Center for Devices and Radiological Health
Error loading feed.
Medical Product Manufacturing News
Error loading feed.
BioSpace.com Featured News and Stories
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
BioSpace.com Career News
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
NC Medical - Twitter Search
Error loading feed.
Biomedical Engineering - Twitter Search
Error loading feed.
Medical Device - Twitter Search
Error loading feed.
Pharmaceutical - Twitter Search
Error loading feed.
Biologics - Twitter Search
Error loading feed.